Profusa, Inc. (PFSA): Operating Income

Annual figures by period end, from SEC filings.

-$27.71M

Year ended 2025-12-31

2022-12-31 Operating Income (USD) 2025-12-31

Period ended	Operating Income	Change YoY	Source filing
2025-12-31	-$27.71M	n/m	2026-04-15, From 2025-01-01
2024-12-31	-$4.50M	n/m	2026-04-15, From 2024-01-01
2023-12-31	-$1.51M	n/m	2025-03-31, From 2023-01-01
2022-12-31	-$1.27M	n/a	2024-02-26, From 2022-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
Profusa, Inc. (PFSA)	2025-12-31	-$27.71M	n/m
Encision Inc (ECIA)	2025-03-31	-$172.0K	n/m
PetVivo Holdings, Inc. (PETV)	2026-03-31	-$9.06M	n/m
Harvard Apparatus Regenerative Technology, Inc. (HRGN)	2025-12-31	-$6.92M	n/m
QTREX Quantum Ltd. (QTEX)	2025-12-31	-$13.62M	n/m
HeartBeam, Inc. (BEATW)	2025-12-31	-$21.14M	n/m
Aethlon Medical Inc (AEMD)	2026-03-31	-$7.29M	n/m
Biotricity Inc. (BTCY)	2026-03-31	$1.69M	n/m
QHSLab, Inc. (USAQ)	2025-12-31	$131.2K	-36.2%

Compare PFSA, ECIA, PETV, HRGN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗